Global Blood Culture Test

Blood Culture Test Comprehensive Study by Type (Consumables (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories), Instruments (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems), Software & Services (Bacterial Infections, Fungal Infections, Mycobacterial Infections)), Application (Bacterial Infections, Fungal Infections, Mycobacterial Infections), Technology (Culture-based Technology, Molecular Technology (PCR, Microarray, PNA-FISH), Proteomic Technology), Technique (Conventional, Automated), End User (Hospitals Laboratories, Reference Laboratories, Others) Players and Region - Global Market Outlook to 2028

Blood Culture Test Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 9.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The growing number of sepsis cases and high cost of treatment and the rising geriatric population will boost the global blood culture test market. Blood culture tests are done to identify the existence of microorganisms including bacteria or fungi in the blood. It is generally used to determine the occurrence of infection, identify the contributing agents, and guide the proper treatment necessary for a patient. Additionally, it is used to recognize a blood infection which if otherwise left unnoticed can lead to a serious and fatal condition called sepsis.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia- Pacific
UnitValue (USD Million)
Key Companies ProfiledBecton, Dickinson, and Company (United States), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (United States), Cepheid, Inc. (United States), Abbott Laboratories (United States), Nanosphere, Inc. (United States), Roche Diagnostics (Switzerland), Beckman Coulter (United States), Bruker Corporation (United States) and IRIDICA (United States)


According to AMA, the market for Blood Culture Test is expected to register a CAGR of 9.1% during the forecast period to 2028. This growth is primarily driven by High Occurrence of Bloodstream Infections and High Prevalence of Infectious Diseases.

Globally, a noticeable market trend is evident Growing Number of Regulatory Approvals & New Product Launches The Health Care Services sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Becton, Dickinson, and Company (United States), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (United States), Cepheid, Inc. (United States), Abbott Laboratories (United States), Nanosphere, Inc. (United States), Roche Diagnostics (Switzerland), Beckman Coulter (United States), Bruker Corporation (United States) and IRIDICA (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The global blood culture test market is highly competitive due to the presence of key market players. To surge the adoption of automated blood culture tests, many key players are establishing or strengthening their research associations to improve safe and efficient products. Additionally, new market players have to develop efficient as well as cost-effective blood culture tests to compete against existing and upcoming market entrants and rise the approval of their products.

Key Developments in the Market:
In May 2022, Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson, and Company), a medical technology company, announced a strategic agreement to expand blood sample collection into new care contexts, including allowing patients to take blood samples at home for diagnostic testing,
On 8th April 2019, BD (Becton, Dickinson, and Company), a leading global medical technology company announced the global availability of BD BACTEC™; platelet quality control media, which allows microbiology laboratories, blood banks, and transfusion services to identify contaminated platelet units.

Regulatory Insights:
In the United States, the Food and Drug Administration (FDA) is the regulatory authority that oversees the approval and regulation of diagnostic tests, including blood culture tests. The FDA ensures that these tests meet certain standards for safety, effectiveness, and accuracy before they can be marketed and used in clinical settings.

Influencing Trend:
Growing Number of Regulatory Approvals & New Product Launches and High Adoption due to Rising Demand for Rapid Diagnostic Techniques

Market Growth Drivers:
High Occurrence of Bloodstream Infections and High Prevalence of Infectious Diseases

Challenges:
Survival of Players Offering Conventional Blood Culture Products and Intense Competition among the Players

Restraints:
Rising Concern about the High Cost of Automated Instruments and Dearth of Skilled Laboratory Technicians

Opportunities:
Identification of Antibiotic-Resistant Microorganisms and Huge Opportunity in Emerging Economies

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Blood Culture Test Market
- Analysis about New Entrants in Blood Culture Test Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Blood Culture Test Study Sheds Light on
— The Blood Culture Test Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Blood Culture Test industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Blood Culture Test industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories]
  • Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems]
  • Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]
By Application
  • Bacterial Infections
  • Fungal Infections
  • Mycobacterial Infections
By Technology
  • Culture-based Technology
  • Molecular Technology [PCR, Microarray, PNA-FISH]
  • Proteomic Technology

By Technique
  • Conventional
  • Automated

By End User
  • Hospitals Laboratories
  • Reference Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Occurrence of Bloodstream Infections
      • 3.2.2. High Prevalence of Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. Survival of Players Offering Conventional Blood Culture Products
      • 3.3.2. Intense Competition among the Players
    • 3.4. Market Trends
      • 3.4.1. Growing Number of Regulatory Approvals & New Product Launches
      • 3.4.2. High Adoption due to Rising Demand for Rapid Diagnostic Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Culture Test, by Type, Application, Technology , Technique, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Blood Culture Test (Value)
      • 5.2.1. Global Blood Culture Test by: Type (Value)
        • 5.2.1.1. Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories]
        • 5.2.1.2. Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems]
        • 5.2.1.3. Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]
      • 5.2.2. Global Blood Culture Test by: Application (Value)
        • 5.2.2.1. Bacterial Infections
        • 5.2.2.2. Fungal Infections
        • 5.2.2.3. Mycobacterial Infections
      • 5.2.3. Global Blood Culture Test by: Technique (Value)
        • 5.2.3.1. Conventional
        • 5.2.3.2. Automated
      • 5.2.4. Global Blood Culture Test by: End User (Value)
        • 5.2.4.1. Hospitals Laboratories
        • 5.2.4.2. Reference Laboratories
        • 5.2.4.3. Others
      • 5.2.5. Global Blood Culture Test Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Blood Culture Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson, and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BioMérieux SA (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cepheid, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nanosphere, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Roche Diagnostics (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Beckman Coulter (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bruker Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. IRIDICA (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Culture Test Sale, by Type, Application, Technology , Technique, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Blood Culture Test (Value)
      • 7.2.1. Global Blood Culture Test by: Type (Value)
        • 7.2.1.1. Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories]
        • 7.2.1.2. Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems]
        • 7.2.1.3. Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]
      • 7.2.2. Global Blood Culture Test by: Application (Value)
        • 7.2.2.1. Bacterial Infections
        • 7.2.2.2. Fungal Infections
        • 7.2.2.3. Mycobacterial Infections
      • 7.2.3. Global Blood Culture Test by: Technique (Value)
        • 7.2.3.1. Conventional
        • 7.2.3.2. Automated
      • 7.2.4. Global Blood Culture Test by: End User (Value)
        • 7.2.4.1. Hospitals Laboratories
        • 7.2.4.2. Reference Laboratories
        • 7.2.4.3. Others
      • 7.2.5. Global Blood Culture Test Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Culture Test: by Type(USD Million)
  • Table 2. Blood Culture Test Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories] , by Region USD Million (2017-2022)
  • Table 3. Blood Culture Test Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems] , by Region USD Million (2017-2022)
  • Table 4. Blood Culture Test Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections] , by Region USD Million (2017-2022)
  • Table 5. Blood Culture Test: by Application(USD Million)
  • Table 6. Blood Culture Test Bacterial Infections , by Region USD Million (2017-2022)
  • Table 7. Blood Culture Test Fungal Infections , by Region USD Million (2017-2022)
  • Table 8. Blood Culture Test Mycobacterial Infections , by Region USD Million (2017-2022)
  • Table 9. Blood Culture Test: by Technique(USD Million)
  • Table 10. Blood Culture Test Conventional , by Region USD Million (2017-2022)
  • Table 11. Blood Culture Test Automated , by Region USD Million (2017-2022)
  • Table 12. Blood Culture Test: by End User(USD Million)
  • Table 13. Blood Culture Test Hospitals Laboratories , by Region USD Million (2017-2022)
  • Table 14. Blood Culture Test Reference Laboratories , by Region USD Million (2017-2022)
  • Table 15. Blood Culture Test Others , by Region USD Million (2017-2022)
  • Table 16. South America Blood Culture Test, by Country USD Million (2017-2022)
  • Table 17. South America Blood Culture Test, by Type USD Million (2017-2022)
  • Table 18. South America Blood Culture Test, by Application USD Million (2017-2022)
  • Table 19. South America Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 20. South America Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 21. South America Blood Culture Test, by End User USD Million (2017-2022)
  • Table 22. Brazil Blood Culture Test, by Type USD Million (2017-2022)
  • Table 23. Brazil Blood Culture Test, by Application USD Million (2017-2022)
  • Table 24. Brazil Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 25. Brazil Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 26. Brazil Blood Culture Test, by End User USD Million (2017-2022)
  • Table 27. Argentina Blood Culture Test, by Type USD Million (2017-2022)
  • Table 28. Argentina Blood Culture Test, by Application USD Million (2017-2022)
  • Table 29. Argentina Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 30. Argentina Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 31. Argentina Blood Culture Test, by End User USD Million (2017-2022)
  • Table 32. Rest of South America Blood Culture Test, by Type USD Million (2017-2022)
  • Table 33. Rest of South America Blood Culture Test, by Application USD Million (2017-2022)
  • Table 34. Rest of South America Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 35. Rest of South America Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 36. Rest of South America Blood Culture Test, by End User USD Million (2017-2022)
  • Table 37. Asia Pacific Blood Culture Test, by Country USD Million (2017-2022)
  • Table 38. Asia Pacific Blood Culture Test, by Type USD Million (2017-2022)
  • Table 39. Asia Pacific Blood Culture Test, by Application USD Million (2017-2022)
  • Table 40. Asia Pacific Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 41. Asia Pacific Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 42. Asia Pacific Blood Culture Test, by End User USD Million (2017-2022)
  • Table 43. China Blood Culture Test, by Type USD Million (2017-2022)
  • Table 44. China Blood Culture Test, by Application USD Million (2017-2022)
  • Table 45. China Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 46. China Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 47. China Blood Culture Test, by End User USD Million (2017-2022)
  • Table 48. Japan Blood Culture Test, by Type USD Million (2017-2022)
  • Table 49. Japan Blood Culture Test, by Application USD Million (2017-2022)
  • Table 50. Japan Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 51. Japan Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 52. Japan Blood Culture Test, by End User USD Million (2017-2022)
  • Table 53. India Blood Culture Test, by Type USD Million (2017-2022)
  • Table 54. India Blood Culture Test, by Application USD Million (2017-2022)
  • Table 55. India Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 56. India Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 57. India Blood Culture Test, by End User USD Million (2017-2022)
  • Table 58. South Korea Blood Culture Test, by Type USD Million (2017-2022)
  • Table 59. South Korea Blood Culture Test, by Application USD Million (2017-2022)
  • Table 60. South Korea Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 61. South Korea Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 62. South Korea Blood Culture Test, by End User USD Million (2017-2022)
  • Table 63. Taiwan Blood Culture Test, by Type USD Million (2017-2022)
  • Table 64. Taiwan Blood Culture Test, by Application USD Million (2017-2022)
  • Table 65. Taiwan Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 66. Taiwan Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 67. Taiwan Blood Culture Test, by End User USD Million (2017-2022)
  • Table 68. Australia Blood Culture Test, by Type USD Million (2017-2022)
  • Table 69. Australia Blood Culture Test, by Application USD Million (2017-2022)
  • Table 70. Australia Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 71. Australia Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 72. Australia Blood Culture Test, by End User USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific Blood Culture Test, by Type USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Blood Culture Test, by Application USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Blood Culture Test, by End User USD Million (2017-2022)
  • Table 78. Europe Blood Culture Test, by Country USD Million (2017-2022)
  • Table 79. Europe Blood Culture Test, by Type USD Million (2017-2022)
  • Table 80. Europe Blood Culture Test, by Application USD Million (2017-2022)
  • Table 81. Europe Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 82. Europe Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 83. Europe Blood Culture Test, by End User USD Million (2017-2022)
  • Table 84. Germany Blood Culture Test, by Type USD Million (2017-2022)
  • Table 85. Germany Blood Culture Test, by Application USD Million (2017-2022)
  • Table 86. Germany Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 87. Germany Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 88. Germany Blood Culture Test, by End User USD Million (2017-2022)
  • Table 89. France Blood Culture Test, by Type USD Million (2017-2022)
  • Table 90. France Blood Culture Test, by Application USD Million (2017-2022)
  • Table 91. France Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 92. France Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 93. France Blood Culture Test, by End User USD Million (2017-2022)
  • Table 94. Italy Blood Culture Test, by Type USD Million (2017-2022)
  • Table 95. Italy Blood Culture Test, by Application USD Million (2017-2022)
  • Table 96. Italy Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 97. Italy Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 98. Italy Blood Culture Test, by End User USD Million (2017-2022)
  • Table 99. United Kingdom Blood Culture Test, by Type USD Million (2017-2022)
  • Table 100. United Kingdom Blood Culture Test, by Application USD Million (2017-2022)
  • Table 101. United Kingdom Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 102. United Kingdom Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 103. United Kingdom Blood Culture Test, by End User USD Million (2017-2022)
  • Table 104. Netherlands Blood Culture Test, by Type USD Million (2017-2022)
  • Table 105. Netherlands Blood Culture Test, by Application USD Million (2017-2022)
  • Table 106. Netherlands Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 107. Netherlands Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 108. Netherlands Blood Culture Test, by End User USD Million (2017-2022)
  • Table 109. Rest of Europe Blood Culture Test, by Type USD Million (2017-2022)
  • Table 110. Rest of Europe Blood Culture Test, by Application USD Million (2017-2022)
  • Table 111. Rest of Europe Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 112. Rest of Europe Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 113. Rest of Europe Blood Culture Test, by End User USD Million (2017-2022)
  • Table 114. MEA Blood Culture Test, by Country USD Million (2017-2022)
  • Table 115. MEA Blood Culture Test, by Type USD Million (2017-2022)
  • Table 116. MEA Blood Culture Test, by Application USD Million (2017-2022)
  • Table 117. MEA Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 118. MEA Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 119. MEA Blood Culture Test, by End User USD Million (2017-2022)
  • Table 120. Middle East Blood Culture Test, by Type USD Million (2017-2022)
  • Table 121. Middle East Blood Culture Test, by Application USD Million (2017-2022)
  • Table 122. Middle East Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 123. Middle East Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 124. Middle East Blood Culture Test, by End User USD Million (2017-2022)
  • Table 125. Africa Blood Culture Test, by Type USD Million (2017-2022)
  • Table 126. Africa Blood Culture Test, by Application USD Million (2017-2022)
  • Table 127. Africa Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 128. Africa Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 129. Africa Blood Culture Test, by End User USD Million (2017-2022)
  • Table 130. North America Blood Culture Test, by Country USD Million (2017-2022)
  • Table 131. North America Blood Culture Test, by Type USD Million (2017-2022)
  • Table 132. North America Blood Culture Test, by Application USD Million (2017-2022)
  • Table 133. North America Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 134. North America Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 135. North America Blood Culture Test, by End User USD Million (2017-2022)
  • Table 136. United States Blood Culture Test, by Type USD Million (2017-2022)
  • Table 137. United States Blood Culture Test, by Application USD Million (2017-2022)
  • Table 138. United States Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 139. United States Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 140. United States Blood Culture Test, by End User USD Million (2017-2022)
  • Table 141. Canada Blood Culture Test, by Type USD Million (2017-2022)
  • Table 142. Canada Blood Culture Test, by Application USD Million (2017-2022)
  • Table 143. Canada Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 144. Canada Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 145. Canada Blood Culture Test, by End User USD Million (2017-2022)
  • Table 146. Mexico Blood Culture Test, by Type USD Million (2017-2022)
  • Table 147. Mexico Blood Culture Test, by Application USD Million (2017-2022)
  • Table 148. Mexico Blood Culture Test, by Technology USD Million (2017-2022)
  • Table 149. Mexico Blood Culture Test, by Technique USD Million (2017-2022)
  • Table 150. Mexico Blood Culture Test, by End User USD Million (2017-2022)
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Blood Culture Test: by Type(USD Million)
  • Table 162. Blood Culture Test Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories] , by Region USD Million (2023-2028)
  • Table 163. Blood Culture Test Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems] , by Region USD Million (2023-2028)
  • Table 164. Blood Culture Test Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections] , by Region USD Million (2023-2028)
  • Table 165. Blood Culture Test: by Application(USD Million)
  • Table 166. Blood Culture Test Bacterial Infections , by Region USD Million (2023-2028)
  • Table 167. Blood Culture Test Fungal Infections , by Region USD Million (2023-2028)
  • Table 168. Blood Culture Test Mycobacterial Infections , by Region USD Million (2023-2028)
  • Table 169. Blood Culture Test: by Technique(USD Million)
  • Table 170. Blood Culture Test Conventional , by Region USD Million (2023-2028)
  • Table 171. Blood Culture Test Automated , by Region USD Million (2023-2028)
  • Table 172. Blood Culture Test: by End User(USD Million)
  • Table 173. Blood Culture Test Hospitals Laboratories , by Region USD Million (2023-2028)
  • Table 174. Blood Culture Test Reference Laboratories , by Region USD Million (2023-2028)
  • Table 175. Blood Culture Test Others , by Region USD Million (2023-2028)
  • Table 176. South America Blood Culture Test, by Country USD Million (2023-2028)
  • Table 177. South America Blood Culture Test, by Type USD Million (2023-2028)
  • Table 178. South America Blood Culture Test, by Application USD Million (2023-2028)
  • Table 179. South America Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 180. South America Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 181. South America Blood Culture Test, by End User USD Million (2023-2028)
  • Table 182. Brazil Blood Culture Test, by Type USD Million (2023-2028)
  • Table 183. Brazil Blood Culture Test, by Application USD Million (2023-2028)
  • Table 184. Brazil Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 185. Brazil Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 186. Brazil Blood Culture Test, by End User USD Million (2023-2028)
  • Table 187. Argentina Blood Culture Test, by Type USD Million (2023-2028)
  • Table 188. Argentina Blood Culture Test, by Application USD Million (2023-2028)
  • Table 189. Argentina Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 190. Argentina Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 191. Argentina Blood Culture Test, by End User USD Million (2023-2028)
  • Table 192. Rest of South America Blood Culture Test, by Type USD Million (2023-2028)
  • Table 193. Rest of South America Blood Culture Test, by Application USD Million (2023-2028)
  • Table 194. Rest of South America Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 195. Rest of South America Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 196. Rest of South America Blood Culture Test, by End User USD Million (2023-2028)
  • Table 197. Asia Pacific Blood Culture Test, by Country USD Million (2023-2028)
  • Table 198. Asia Pacific Blood Culture Test, by Type USD Million (2023-2028)
  • Table 199. Asia Pacific Blood Culture Test, by Application USD Million (2023-2028)
  • Table 200. Asia Pacific Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 201. Asia Pacific Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 202. Asia Pacific Blood Culture Test, by End User USD Million (2023-2028)
  • Table 203. China Blood Culture Test, by Type USD Million (2023-2028)
  • Table 204. China Blood Culture Test, by Application USD Million (2023-2028)
  • Table 205. China Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 206. China Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 207. China Blood Culture Test, by End User USD Million (2023-2028)
  • Table 208. Japan Blood Culture Test, by Type USD Million (2023-2028)
  • Table 209. Japan Blood Culture Test, by Application USD Million (2023-2028)
  • Table 210. Japan Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 211. Japan Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 212. Japan Blood Culture Test, by End User USD Million (2023-2028)
  • Table 213. India Blood Culture Test, by Type USD Million (2023-2028)
  • Table 214. India Blood Culture Test, by Application USD Million (2023-2028)
  • Table 215. India Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 216. India Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 217. India Blood Culture Test, by End User USD Million (2023-2028)
  • Table 218. South Korea Blood Culture Test, by Type USD Million (2023-2028)
  • Table 219. South Korea Blood Culture Test, by Application USD Million (2023-2028)
  • Table 220. South Korea Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 221. South Korea Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 222. South Korea Blood Culture Test, by End User USD Million (2023-2028)
  • Table 223. Taiwan Blood Culture Test, by Type USD Million (2023-2028)
  • Table 224. Taiwan Blood Culture Test, by Application USD Million (2023-2028)
  • Table 225. Taiwan Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 226. Taiwan Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 227. Taiwan Blood Culture Test, by End User USD Million (2023-2028)
  • Table 228. Australia Blood Culture Test, by Type USD Million (2023-2028)
  • Table 229. Australia Blood Culture Test, by Application USD Million (2023-2028)
  • Table 230. Australia Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 231. Australia Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 232. Australia Blood Culture Test, by End User USD Million (2023-2028)
  • Table 233. Rest of Asia-Pacific Blood Culture Test, by Type USD Million (2023-2028)
  • Table 234. Rest of Asia-Pacific Blood Culture Test, by Application USD Million (2023-2028)
  • Table 235. Rest of Asia-Pacific Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 236. Rest of Asia-Pacific Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 237. Rest of Asia-Pacific Blood Culture Test, by End User USD Million (2023-2028)
  • Table 238. Europe Blood Culture Test, by Country USD Million (2023-2028)
  • Table 239. Europe Blood Culture Test, by Type USD Million (2023-2028)
  • Table 240. Europe Blood Culture Test, by Application USD Million (2023-2028)
  • Table 241. Europe Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 242. Europe Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 243. Europe Blood Culture Test, by End User USD Million (2023-2028)
  • Table 244. Germany Blood Culture Test, by Type USD Million (2023-2028)
  • Table 245. Germany Blood Culture Test, by Application USD Million (2023-2028)
  • Table 246. Germany Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 247. Germany Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 248. Germany Blood Culture Test, by End User USD Million (2023-2028)
  • Table 249. France Blood Culture Test, by Type USD Million (2023-2028)
  • Table 250. France Blood Culture Test, by Application USD Million (2023-2028)
  • Table 251. France Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 252. France Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 253. France Blood Culture Test, by End User USD Million (2023-2028)
  • Table 254. Italy Blood Culture Test, by Type USD Million (2023-2028)
  • Table 255. Italy Blood Culture Test, by Application USD Million (2023-2028)
  • Table 256. Italy Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 257. Italy Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 258. Italy Blood Culture Test, by End User USD Million (2023-2028)
  • Table 259. United Kingdom Blood Culture Test, by Type USD Million (2023-2028)
  • Table 260. United Kingdom Blood Culture Test, by Application USD Million (2023-2028)
  • Table 261. United Kingdom Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 262. United Kingdom Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 263. United Kingdom Blood Culture Test, by End User USD Million (2023-2028)
  • Table 264. Netherlands Blood Culture Test, by Type USD Million (2023-2028)
  • Table 265. Netherlands Blood Culture Test, by Application USD Million (2023-2028)
  • Table 266. Netherlands Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 267. Netherlands Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 268. Netherlands Blood Culture Test, by End User USD Million (2023-2028)
  • Table 269. Rest of Europe Blood Culture Test, by Type USD Million (2023-2028)
  • Table 270. Rest of Europe Blood Culture Test, by Application USD Million (2023-2028)
  • Table 271. Rest of Europe Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 272. Rest of Europe Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 273. Rest of Europe Blood Culture Test, by End User USD Million (2023-2028)
  • Table 274. MEA Blood Culture Test, by Country USD Million (2023-2028)
  • Table 275. MEA Blood Culture Test, by Type USD Million (2023-2028)
  • Table 276. MEA Blood Culture Test, by Application USD Million (2023-2028)
  • Table 277. MEA Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 278. MEA Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 279. MEA Blood Culture Test, by End User USD Million (2023-2028)
  • Table 280. Middle East Blood Culture Test, by Type USD Million (2023-2028)
  • Table 281. Middle East Blood Culture Test, by Application USD Million (2023-2028)
  • Table 282. Middle East Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 283. Middle East Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 284. Middle East Blood Culture Test, by End User USD Million (2023-2028)
  • Table 285. Africa Blood Culture Test, by Type USD Million (2023-2028)
  • Table 286. Africa Blood Culture Test, by Application USD Million (2023-2028)
  • Table 287. Africa Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 288. Africa Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 289. Africa Blood Culture Test, by End User USD Million (2023-2028)
  • Table 290. North America Blood Culture Test, by Country USD Million (2023-2028)
  • Table 291. North America Blood Culture Test, by Type USD Million (2023-2028)
  • Table 292. North America Blood Culture Test, by Application USD Million (2023-2028)
  • Table 293. North America Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 294. North America Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 295. North America Blood Culture Test, by End User USD Million (2023-2028)
  • Table 296. United States Blood Culture Test, by Type USD Million (2023-2028)
  • Table 297. United States Blood Culture Test, by Application USD Million (2023-2028)
  • Table 298. United States Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 299. United States Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 300. United States Blood Culture Test, by End User USD Million (2023-2028)
  • Table 301. Canada Blood Culture Test, by Type USD Million (2023-2028)
  • Table 302. Canada Blood Culture Test, by Application USD Million (2023-2028)
  • Table 303. Canada Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 304. Canada Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 305. Canada Blood Culture Test, by End User USD Million (2023-2028)
  • Table 306. Mexico Blood Culture Test, by Type USD Million (2023-2028)
  • Table 307. Mexico Blood Culture Test, by Application USD Million (2023-2028)
  • Table 308. Mexico Blood Culture Test, by Technology USD Million (2023-2028)
  • Table 309. Mexico Blood Culture Test, by Technique USD Million (2023-2028)
  • Table 310. Mexico Blood Culture Test, by End User USD Million (2023-2028)
  • Table 311. Research Programs/Design for This Report
  • Table 312. Key Data Information from Secondary Sources
  • Table 313. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Culture Test: by Type USD Million (2017-2022)
  • Figure 5. Global Blood Culture Test: by Application USD Million (2017-2022)
  • Figure 6. Global Blood Culture Test: by Technique USD Million (2017-2022)
  • Figure 7. Global Blood Culture Test: by End User USD Million (2017-2022)
  • Figure 8. South America Blood Culture Test Share (%), by Country
  • Figure 9. Asia Pacific Blood Culture Test Share (%), by Country
  • Figure 10. Europe Blood Culture Test Share (%), by Country
  • Figure 11. MEA Blood Culture Test Share (%), by Country
  • Figure 12. North America Blood Culture Test Share (%), by Country
  • Figure 13. Global Blood Culture Test share by Players 2022 (%)
  • Figure 14. Global Blood Culture Test share by Players (Top 3) 2022(%)
  • Figure 15. Global Blood Culture Test share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson, and Company (United States) Revenue: by Geography 2022
  • Figure 19. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 20. BioMérieux SA (France) Revenue: by Geography 2022
  • Figure 21. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Cepheid, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cepheid, Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 27. Nanosphere, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Nanosphere, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Roche Diagnostics (Switzerland) Revenue: by Geography 2022
  • Figure 31. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 32. Beckman Coulter (United States) Revenue: by Geography 2022
  • Figure 33. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Bruker Corporation (United States) Revenue: by Geography 2022
  • Figure 35. IRIDICA (United States) Revenue, Net Income and Gross profit
  • Figure 36. IRIDICA (United States) Revenue: by Geography 2022
  • Figure 37. Global Blood Culture Test: by Type USD Million (2023-2028)
  • Figure 38. Global Blood Culture Test: by Application USD Million (2023-2028)
  • Figure 39. Global Blood Culture Test: by Technique USD Million (2023-2028)
  • Figure 40. Global Blood Culture Test: by End User USD Million (2023-2028)
  • Figure 41. South America Blood Culture Test Share (%), by Country
  • Figure 42. Asia Pacific Blood Culture Test Share (%), by Country
  • Figure 43. Europe Blood Culture Test Share (%), by Country
  • Figure 44. MEA Blood Culture Test Share (%), by Country
  • Figure 45. North America Blood Culture Test Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson, and Company (United States)
  • bioMérieux SA (France)
  • Thermo Fisher Scientific, Inc. (United States)
  • Cepheid, Inc. (United States)
  • Abbott Laboratories (United States)
  • Nanosphere, Inc. (United States)
  • Roche Diagnostics (Switzerland)
  • Beckman Coulter (United States)
  • Bruker Corporation (United States)
  • IRIDICA (United States)
Additional players considered in the study are as follows:
T2 Biosystems (United States) , Danaher Corporation (United States) , Luminex Corporation (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 228 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Culture Test Quantitative research analysis
Global Blood Culture Test Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Blood Culture Test market are Becton, Dickinson, and Company (United States), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (United States), Cepheid, Inc. (United States), Abbott Laboratories (United States), Nanosphere, Inc. (United States), Roche Diagnostics (Switzerland), Beckman Coulter (United States), Bruker Corporation (United States) and IRIDICA (United States), to name a few.
North America is dominating the Blood Culture Test Market.
"Survival of Players Offering Conventional Blood Culture Products " is seen as one of the major challenges by many Industry Players of Blood Culture Test Market
The Blood Culture Test market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Blood Culture Test market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Blood Culture Test Report?

Have a Query? Click Here

Other Related Reports

Syphilis Testing Comprehensive Study by Type (Treponemal tests, Non-treponemal tests), Syphilis types (Primary Syphilis, Secondary Syphilis, Others (Latent (hidden) stage, Tertiary (late) stage)), G...
$ 3450
Bioactive Wound Management Comprehensive Study by Type (Moist Wound Care, Antimicrobial Wound Care, Others), Application (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Bu...
$ 3750
Ophthalmological Ultrasound Systems Comprehensive Study by Type (A- Scan, B- Scan, Combined Scan, Pachymeter, Ultrasound Bio-microscopy (UBM)), Modality (Portable, Standalone), End User (Hospitals, O...
$ 3350
Clean Room Panels Comprehensive Study by Type (Cleanroom wall Panels, Cleanroom Ceiling Panels, Cleanroom Door Panels, Cleanroom Window Panels, Cleanroom Floor Panels), Application (Food Industry, Op...
$ 3450
Troponin Diagnostic Tests Comprehensive Study by Type (Troponin I ELISA Test, Troponin Rapid test), Sales Channels (Online Sales Channel {Company Website, E-Commerce Platform}, Offline Sales Channels...
$ 3750
Tele-Intensive Care Unit Comprehensive Study by Type (Centralized, Decentralized, Other (Hybrid)), (), Component (Hardware (Computer System, Communication Lines, Physiological Monitors, Therapeutic ...
$ 3350